Cargando…

Identification of a novel PPARβ/δ/miR‐21‐3p axis in UV‐induced skin inflammation

Although excessive exposure to UV is widely recognized as a major factor leading to skin perturbations and cancer, the complex mechanisms underlying inflammatory skin disorders resulting from UV exposure remain incompletely characterized. The nuclear hormone receptor PPARβ/δ is known to control mous...

Descripción completa

Detalles Bibliográficos
Autores principales: Degueurce, Gwendoline, D'Errico, Ilenia, Pich, Christine, Ibberson, Mark, Schütz, Frédéric, Montagner, Alexandra, Sgandurra, Marie, Mury, Lionel, Jafari, Paris, Boda, Akash, Meunier, Julien, Rezzonico, Roger, Brembilla, Nicolò Costantino, Hohl, Daniel, Kolios, Antonios, Hofbauer, Günther, Xenarios, Ioannis, Michalik, Liliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967944/
https://www.ncbi.nlm.nih.gov/pubmed/27250636
http://dx.doi.org/10.15252/emmm.201505384
Descripción
Sumario:Although excessive exposure to UV is widely recognized as a major factor leading to skin perturbations and cancer, the complex mechanisms underlying inflammatory skin disorders resulting from UV exposure remain incompletely characterized. The nuclear hormone receptor PPARβ/δ is known to control mouse cutaneous repair and UV‐induced skin cancer development. Here, we describe a novel PPARβ/δ‐dependent molecular cascade involving TGFβ1 and miR‐21‐3p, which is activated in the epidermis in response to UV exposure. We establish that the passenger miRNA miR‐21‐3p, that we identify as a novel UV‐induced miRNA in the epidermis, plays a pro‐inflammatory function in keratinocytes and that its high level of expression in human skin is associated with psoriasis and squamous cell carcinomas. Finally, we provide evidence that inhibition of miR‐21‐3p reduces UV‐induced cutaneous inflammation in ex vivo human skin biopsies, thereby underlining the clinical relevance of miRNA‐based topical therapies for cutaneous disorders.